GRAY
Price:
$5.5
Market Cap:
$120.98M
Graybug Vision, Inc. is a biopharmaceutical company currently in its clinical development phase, dedicated to creating treatments for conditions affecting the eye's retina and optic nerve. Its flagship therapeutic, GB-102, is an injectable microparticle formulation of sunitinib administered directly into the eye. This compound is progressing through Phase I/IIa and IIb clinical trials for wet age-related macular degeneration, while also undergoing Phase IIa trials for diabetic macular edema. Furthermore, GB-102 is being explored as a treatment for diabetic retinopathy. The company's pipeline also includes GB-401, an intraocular implant designed to deliver a beta-adrenergic receptor inhibitor...[Read more]
Industry
Biotechnology
IPO Date
2020-09-04
Stock Exchange
NASDAQ
Ticker
GRAY
According to Graybug Vision, Inc.’s latest financial reports and current stock price. The company's current ROE is 4.09%. This represents a change of 548.23% compared to the average of 631.41% of the last 4 quarters.
The mean historical ROE of Graybug Vision, Inc. over the last ten years is -28.31%. The current 4.09% ROE has changed -14559.66% with respect to the historical average. Over the past ten years (40 quarters), GRAY's ROE was at its highest in in the September 2025 quarter at 2.91%. The ROE was at its lowest in in the March 2026 quarter at -450.72%.
Average
-28.31%
Median
-95.07%
Minimum
-236.11%
Maximum
445.14%
Discovering the peaks and valleys of Graybug Vision, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 89.67%
Maximum Annual ROE = 445.14%
Minimum Annual Increase = -568.21%
Minimum Annual ROE = -236.11%
| Year | ROE | Change |
|---|---|---|
| 2025 | 445.14% | -568.21% |
| 2024 | -95.07% | -3.95% |
| 2022 | -98.98% | 79.68% |
| 2021 | -55.09% | 89.67% |
| 2020 | -29.05% | -77.48% |
| 2019 | -128.99% | -45.37% |
The current ROE of Graybug Vision, Inc. (GRAY) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
83.70%
5-year avg
33.39%
10-year avg
-28.31%
Graybug Vision, Inc.’s ROE is greater than Kinnate Biopharma Inc. (-58.86%), greater than NGM Biopharmaceuticals, Inc. (-69.76%), greater than Decibel Therapeutics, Inc. (-56.38%), greater than Tourmaline Bio, Inc. (-24.42%), greater than RVL Pharmaceuticals plc (-80.88%), less than Paratek Pharmaceuticals, Inc. (42.54%), greater than Sesen Bio, Inc. (-111.70%), greater than aTyr Pharma, Inc. (-99.87%), greater than Quoin Pharmaceuticals, Ltd. (-292.33%), greater than Cyteir Therapeutics, Inc. (-26.35%),
| Company | ROE | Market cap |
|---|---|---|
| -58.86% | $124.99M | |
| -69.76% | $128.53M | |
| -56.38% | $123.37M | |
| -24.42% | $1.23B | |
| -80.88% | $3.14M | |
| 42.54% | $127.83M | |
| -111.70% | $127.96M | |
| -99.87% | $43.18M | |
| -292.33% | $8.43M | |
| -26.35% | $108.71M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Graybug Vision, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Graybug Vision, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Graybug Vision, Inc.'s ROE?
How is the ROE calculated for Graybug Vision, Inc. (GRAY)?
What is the highest ROE for Graybug Vision, Inc. (GRAY)?
What is the 3-year average ROE for Graybug Vision, Inc. (GRAY)?
What is the 5-year average ROE for Graybug Vision, Inc. (GRAY)?
How does the current ROE for Graybug Vision, Inc. (GRAY) compare to its historical average?